Steriles Express Early Development

Delays in early development put funding, milestones, and patient access at risk. This offering for Phase 1 and 2 sterile products takes a different approach to the schedule: a contractual commitment to deliver a GMP clinical batch within 20 weeks of project kick-off, backed by a timeline guarantee that credits the client if delivery slips.

It applies to 2R, 6R, 10R, and 20R vials with batch sizes of up to 10,000 units, and it combines analytical services, microbiology, laboratory-scale manufacturing, technical documentation, and clinical trial material production under one team. Pricing is milestone-based, and a list of optional add-on services sits outside the guarantee.

Review the program scope, the delivery terms, and the track record behind them to see how the model works.